Stratos Wealth Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-21,110
| Closed | -$260K | – | 1059 |
|
|
2020
Q2 | $260K | Sell |
21,110
-3,450
| -14% | -$42.5K | 0.01% | 810 |
|
|
2020
Q1 | $221K | Buy |
24,560
+14,000
| +133% | +$126K | 0.01% | 783 |
|
|
2019
Q4 | $103K | Buy |
+10,560
| New | +$103K | ﹤0.01% | 951 |
|
|
2018
Q4 | – | Sell |
-3,690
| Closed | -$79K | – | 2330 |
|
|
2018
Q3 | $79K | Buy |
+3,690
| New | +$79K | ﹤0.01% | 1251 |
|
|
2018
Q2 | – | Sell |
-4,039
| Closed | -$69K | – | 2408 |
|
|
2018
Q1 | $69K | Sell |
4,039
-1,111
| -22% | -$19K | ﹤0.01% | 1405 |
|
|
2017
Q4 | $98K | Buy |
+5,150
| New | +$98K | ﹤0.01% | 1199 |
|
|
2017
Q1 | – | Sell |
-9,969
| Closed | -$361K | – | 855 |
|
|
2016
Q4 | $361K | Sell |
9,969
-5,602
| -36% | -$203K | 0.02% | 469 |
|
|
2016
Q3 | $716K | Buy |
15,571
+2,303
| +17% | +$106K | 0.05% | 289 |
|
|
2016
Q2 | $666K | Buy |
13,268
+8,768
| +195% | +$440K | 0.05% | 283 |
|
|
2016
Q1 | $241K | Buy |
4,500
+592
| +15% | +$31.7K | 0.02% | 471 |
|
|
2015
Q4 | $257K | Buy |
+3,908
| New | +$257K | 0.02% | 462 |
|
|
2015
Q1 | – | Sell |
-3,551
| Closed | -$204K | – | 633 |
|
|
2014
Q4 | $204K | Buy |
+3,551
| New | +$204K | 0.04% | 447 |
|